3 jobs found in Burlington, VT

We are looking to fill a Principal IT Business Analyst position to join our expanding IT team. We drive the business forward by delivering new digital capabilities and technologies. Our Principal IT Business Analysts support the organization by eliciting and documenting requirements, understanding complex business processes, and coordinating communication among the various groups. In this dynamic environment, Principal IT Business Analysts have an opportunity to work on numerous aspects of the process and business. As a Principal IT Business Analyst, a typical day might include the following: Works closely with IT management and business partners to elicit detailed requirements and document value streams and processes in support of delivering new business capabilities; Partners with a diverse business community to document complex and cross-functional as-is and to-be business processes and identify gaps between them; Documents clear and testable functional and non-functional...

Regeneron Pharmaceuticals is seeking a Manager, Financial Planning & Analysis to act as a leading business partner to the Rensselaer IOPS (Industrial Operations and Product Supply) functions. You will be responsible for supporting financial and operational decisions through business planning, forecasting, analysis, and management financial reporting. Providing related insights for key business partners in a growing, fast paced environment. As a Manager, Financial Planning & Analysis, a typical day might include the following: Business Partnership: Collaborate with various IOPS departments, to understand their financial needs, provide financial guidance, and support strategic initiatives. Act as a business partner by providing financial insights and recommendations to drive business performance. Data Analysis and Interpretation: Analyze large volumes of financial and operational data to identify trends, patterns, and insights. Extract relevant information, perform data...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...